Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

• Status: Completed
• Trial end date: 2005-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the safety and effectiveness of ciclesonide nasal spray as compared with placebo (inactive substance) nasal spray in relieving symptoms of perennial allergic rhinitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Ciclesonide

Criteria

Main Inclusion Criteria:

• General good health, other than perennial allergic rhinitis

• History and diagnosis of perennial allergic rhinitis by skin prick test

Main Exclusion Criteria:

• Participation in any investigational drug trial within the 30 days preceding the Screening Visit

• A known hypersensitivity to any corticosteroid or any of the excipients in the formulation

• Use of any prohibited concomitant medications as defined by the study protocol